Central nervous system neurotransmitter pathways

Central nervous system (CNS) neurotransmitter pathways represent the integrated networks of chemical signaling that facilitate communication between neurons and effector cells [1]. These pathways are categorized by the specific neurotransmitters they utilize, such as glutamate for excitation, GABA for inhibition, and biogenic amines like dopamine and serotonin for neuromodulation [1]. They play a fundamental role in regulating physiological processes including motor coordination, cognitive function, mood, and autonomic homeostasis [2]. Dysregulation within these pathways is a hallmark of numerous pathological states, including neurodegenerative diseases like Parkinson's and Alzheimer's, as well as psychiatric disorders such as schizophrenia and major depressive disorder [3]. Therapeutic strategies often target specific components of these pathways, including receptors, transporters, and metabolic enzymes, to modulate synaptic plasticity and restore neurochemical balance [1]. Because these pathways are highly interconnected, pharmacological intervention in one system often produces downstream effects across the broader CNS network [2].

Other names

CNS neurotransmissionNeurotransmitter systemsSynaptic transmission pathwaysChemical signaling pathways

Drugs targeting these pathways function through various mechanisms, including acting as receptor agonists or antagonists, inhibiting neurotransmitter reuptake transporters, or modulating enzymes responsible for neurotransmitter synthesis and degradation [1].